Abstract Background/Aims: Recent studies have indicated that microRNA-21 (miR-21) is involved in the inflammatory response in relation to renal disease. Sirtuin1 (SIRT1) exerts renoprotective properties by counteracting inflammation. The activation of CD40 triggers inflammation that participates in renal inflammation and injury. The relationship between miR-21, SIRT1 and CD40, however, remains elusive. Methods: Immunohistochemistry, small-interfering RNA (siRNA) transfection, quantitative real-time PCR and western blotting were applied to assess the morphological, functional and molecular mechanisms in primary cultured renal inner medullary collecting duct (IMCD) cells. Results: TNF-α induced miR-21, CD40 and acetylated-NF-κBp65 (Ac-p65) expressions and reduced SIRT1 expression in IMCD cells. miR-21 mimics increased SIRT1 expression and attenuated Ac-p65 and CD40 expressions in TNF-α-induced IMCD cells, and the corresponding changes were observed with a miR-21 inhibitor. SIRT1 overexpression or activation by SRT1720 diminished TNF-α-induced CD40 and Ac-p65 expressions, which was reversed by SIRT1 siRNA or the inhibitors Ex527 and sirtinol and augmented by pretreatment with NF-κB siRNA. Further study found that the inhibitory effect of miR-21 on Ac-p65 and CD40 expressions was impeded by pretreatment with SIRT1 siRNA. Conclusion: The present study indicates that miR-21 inhibits TNF-α-induced CD40 expression in IMCD cells via the SIRT1-NF-κB signalling pathway, which provides new insight in understanding the anti-inflammatory effect of miR-21.
MiR-21 Regulates TNF-α-Induced CD40 Expression via the SIRT1-NF-κB Pathway in

Introduction
Sirtuin 1 (SIRT1), an NAD + -dependent class III histone/protein deacetylases, has been shown to play an important role in the regulation of inflammation associated with disease by suppressing the release of pro-inflammatory cytokines [1, 2] . Recently, emerging evidences miR-21 mimics and inhibitors, small interfering RNAs (siRNAs) against SIRT1 and NF-κBp65, as well as a negative control were synthesized by GenePharma (GenePharma Co., Ltd., Shanghai, China) (http://www.genepharma.com) with the following sequences: miR-21 mimics forward 5ˊ-UAGCUUAUCAGACUGAUGUUGA-3ˊand reverse 5ˊ-AACAUCAGUCUGAUA AGCUAUU-3ˊ; miR-21 inhibitor 5′-UCAACAUCAGUCUGAUAACUA-3′; SIRT1 siRNA forward 5ˊ-CCCUGUAAAGCUUUCAGAATT-3ˊ and reverse 5ˊ-UUCUGAAAGCUUUACAG GGTT-3ˊ; NF-κBp65 siRNA forward 5ˊ-GGAGUACCCUGAAGCUAUATT-3ˊ and reverse 5ˊ-UAUAGCUUCAGGGUACUCCTT-3ˊ; Negative control forward 5ˊ-UUCUCCGAACGUGUCA CGUTT-3ˊ and reverse 5ˊ-ACGUGACACGUUCGGAGAATT-3ˊ.
Primary culture of rat kidney IMCD cells
Primary cultures enriched in IMCD cells were prepared from male Sprague-Dawley rats (120-140 g body wt), as previously described [34] . All experimental protocols were approved by the Review Committee for the Use of Human or Animal Subjects of Yanshan University. Both kidneys were rapidly removed from rats under light diethyl ether inhalation anaesthesia. After kidney excision, the renal inner medullas including papilla were rapidly removed, cut into small pieces, and digested in phosphate-buffered saline (PBS) containing 1 mg/ml hyaluronidase and 2.2 mg/ml collagenase type CLS-II at 37℃ under continuous agitation for 90 min. After centrifugation, the pellet was washed in prewarmed culture medium (Dulbecco's modified Eagle's medium containing 100 mM NaCl, 100 mM urea, 1% non-essential amino acids, 1% ultroser, 500 μM DBcAMP, 20 U/ml nystatin and 0.25 μg/ml gentamicin). The resulting IMCD cell suspension was seeded in 60 mm culture dish and incubated with treatments described in the Results section.
Immunofluorescence staining IMCD cells were fixed in 10% paraformaldehyde-PBS for 30 min. The fixed cell membrane was fenestrated with 0.5% Triton X-100 in PBS for 5 min, and then blocked with 5% goat serum for 30 min. The cells were incubated with polyclonal anti-rabbit AQP2 antibody (1:100 dilutions) overnight at 4℃, and then incubated with a FITC-conjugated goat anti-rabbit IgG polyclonal antibody (1:100 dilutions) for 2 h. After the nuclei were stained with 4'-6-diamidino-2-phenylindole (DAPI) dye (1:800 dilutions) for 15 min, the stained cells were investigated using confocal laser scanning microscopy (Nikon, Tokyo, Japan).
Immunohistochemical examination IMCD cells were fixed in 10% paraformaldehyde in PBS for 30 min and then washed three times with PBS. The fixed cells were permeabilized with 0.5% Triton X-100 in PBS for 5 min at room temperature and washed three times with PBS. Endogenous peroxidase activity was blocked by treating the sections with 3% hydrogen peroxide in phosphate-buffered saline for 10 min. The cells were then blocked with 5% bovine serum albumin (BSA) in PBS at room temperature for 30 min. To detect CD40 protein expression, a rabbit anti-CD40 polyclonal antibody (1:100 dilutions in PBS) was incubated with cells overnight at 4℃. After being washed three times with PBS, the cells were incubated with secondary antibodies for 30 min at room temperature. Finally, the cells were developed by applying diaminobenzidine as a chromogen, followed by counterstaining with haematoxylin. The cells that had not been incubated with primary antibodies served as negative controls. The optical density of the scanned images was computerized using a digital image analyser by IMAGE-PRO PLUS 6.0 (Media Cybernetics).
Transient transfection
The recombinant plasmid pcDNA3.1(+)-SIRT1 was provided by Dr. Bu. The recombinant plasmid pcDNA3.1(+)-SIRT1 was confirmed by restriction enzyme analysis and DNA sequencing. For transfection, IMCD cells were plated on 6-well plates. For the SIRT1 overexpression experiments, the cells were transiently transfected for 48 h with pcDNA3.1(+)-SIRT1 or pcDNA3.1(+) using Lipofectamine 2000, according to the manufacturer's protocol. After 48 h, transfected cells were harvested and analysed by western blotting to detect the level of SIRT1 expression.
RNA interference
The cells were transfected with 20 μM synthesized siRNA targeting rat SIRT1 and NF-κBp65, and scrambled siRNA was used as a negative control (NC siRNA). The siRNA and Lipofectamine 2000 were separately diluted in serum-free DMEM and incubated for 5 min at room temperature. Then the two solutions were gently mixed and incubated for 20 min, followed by addition to the cells. The IMCD cells were transfected with siRNA Lipofectamine complexes and incubated for 48 h at 37℃ in a CO 2 incubator, and then were used in the experiments.
For overexpression or knockdown of miR-21, cells were transfected with either 100 nM miR-21 mimics, inhibitors or miR-control (NC mimics and inhibitor). All miRNAs were transfected into IMCD cells with Lipofectamine 2000 in accordance with the manufacturer's procedure. After 48 h of incubation, the cells were processed for further analysis.
Western blot
Protein samples were separated by 10~12% SDS-PAGE gels and transferred to polyvinylidene difluoride (PVDF) membranes (Millipore). The membranes were blocked in 5% non-fat dry milk for 1 h. After blocking, the following primary antibodies were utilized: rabbit polyclonal anti-SIRT1 (1:400 dilutions); anti-CD40 (1:500 dilutions); anti-Ac-p65 (1:500 dilutions); anti-NF-κBp65 (1:800 dilutions), and anti-GAPDH (1:5000 dilutions). The membranes were incubated with horseradish peroxidase-conjugated secondary antibodies (1:10000 dilutions). Protein bands were subsequently detected with enhanced chemiluminescence (ECL System; Millipore), and sections were exposed to X-ray film (Kodak). GAPDH was used as an internal control.
Quantitative real-time polymerase chain reaction (RT-qPCR)
Total RNA was extracted from IMCD cells using TRIzol reagent (Life Technologies, Foster, CA, USA). Complementary DNA was synthesized using a PrimeScript RT reagent kit (Perfect RealTime; TaKaRa). The RT-qPCR was performed using SYBR Green PCR master mix (TaKaRa) on a Bio-Rad CFX connect real-time system (Bio-Rad, Hercules, CA, USA), following the manufacturer's instructions. The samples were run in triplicate. The following primers were used for amplification: SIRT1 forward 5ˊ-CAGTTCCAGCCATCTCTGTG-3ˊ and reverse 5ˊ-GCAAC CTGCTCCAAGGTATC-3ˊ; CD40 forward 5'-TAGCCACTGCACAGCTCTTG-3' and reverse 5'-GAAGCCCTTGATTGAGTTCG-3'; GAPDH forward 5ˊ-ACAGCAACAGGGTGGTGGAC-3ˊand reverse 5ˊ-TTTGAGGGTGCAGCGAACTT-3ˊ. GAPDH was used as an endogenous control. Quantification of relative gene expression was calculated by the comparative Ct method (2 -△△Ct ) as described by the manufacturer. Data were normalized to rat GAPDH mRNA levels. Three independent experiments were performed to study mRNA levels.
Expression levels of mature miR-21 were detected using a PrimeScript TM miRNA qPCR Kit (TaKaRa) according to the manufacturer's instructions. The samples were run in triplicate. U6 was used as an endogenous control. The miR-21 and U6 primers were obtained from TaKaRa. Quantification of relative gene expression was calculated by the comparative Ct method (2 -△△Ct ) as described by the manufacturer. Data were normalized to rat U6 levels. Three independent experiments were performed to study miRNA levels.
Statistical analyses
All values in the results are expressed as the mean ± SD. Statistical significance between means was analysed by one-way ANOVA followed by a post hoc test. A value of P < 0.05 was considered statistically significant.
Results
TNF-α increases CD40 expression in IMCD cells
It is well known that aquaporins (AQPs; a family of water channel proteins), especially AQP2, play major role in water reabsorption in renal IMCD cells. To determine whether the IMCD cells are functional, labelled AQP2 was examined in IMCD cells after short-term 1-desamino-8-D-arginine vasopressin (dDAVP) treatment. Our results revealed that AQP2 was largely dispersed within the cytoplasm of IMCD cells. Interestingly, treatment with 100 nM AVP for 30 min clearly increased the AQP2 expression in the plasma membrane and decreased it in the cytoplasm (Fig. 1A) , indicating that the IMCD cells were correctly cultured.
To determine whether CD40 is expressed in IMCD cells, immunohistochemical staining was performed. The results showed that CD40 was dispersed in the cytoplasm of primary for the indicated time, and the expression level of miR-21 was determined by RT-qPCR. **P < 0.01 vs. control group. (C) IMCD cells were transfected with miR-21 mimics or negative control mimics (NC mimics) for 48 h, and the expression level of miR-21 was detected by RT-qPCR. **P < 0.01 vs. NC mimics group. (D) IMCD cells were transfected with miR-21 inhibitor or negative control inhibitor (NC inhibitor) for 48 h, and the expression level of miR-21 was detected by RT-qPCR. **P < 0.01 vs. NC inhibitor group. (E and F) The IMCD cells transfected with miR-21 mimics were treated with TNF-α (20 μg/L) for 24 h, and the protein and mRNA expression of CD40 was examined by western blotting and RT-qPCR, respectively. **P < 0.01 vs. NC mimics group; ## P < 0.01 vs. NC mimics + TNF-α group. (G and H) The IMCD cells transfected with miR-21 inhibitor were treated with TNF-α (20 μg/L) for 24 h, and the protein and mRNA expression of CD40 was examined by western blotting and RT-qPCR, respectively. *P < 0.05 and **P < 0.01 vs. NC inhibitor group; ## P < 0.01 vs. NC inhibitor + TNF-α group. The results are expressed as the means ± SD from triplicate experiments. cultured IMCD cells in the absence of TNF-α stimulation. Moreover, treatment with 20 μg/L TNF-α for 24 h was associated with an increase in CD40 immunohistochemical staining of the cytoplasm. Image analysis further demonstrated that the optical density of CD40 was significantly higher in the TNF-α group compared with the control group (Fig. 1B) . To further investigate whether CD40 expression could be regulated by TNF-α in IMCD cells, western blotting and RT-qPCR were used. The results revealed that treatment of IMCD cells with TNF-α (10, 20 and 40 μg/L) for 24 h significantly increased the expression of CD40 mRNA and protein in a concentration-dependent manner ( Fig. 1C and D) . To further investigate the effect of TNF-α within various time points, the cells were stimulated with TNF-α (20 μg/L) for 4, 8, 12 and 24 h. The results showed that TNF-α increased the expression of CD40 mRNA and protein in a time-dependent manner ( Fig. 1E and F) .
miR-21 regulates TNF-α-induced CD40 expression in IMCD cells
To explore whether TNF-α influenced miR-21 expression, IMCD cells were treated with different concentrations of TNF-α (10, 20 and 40 μg/L) for 24 h, and the expression level of miR-21 was determined using RT-qPCR. We found that treatment of cells with TNF-α significantly increased the expression level of miR-21in a concentration-dependent manner ( Fig. 2A) . We further studied the time course of the miR-21 expression level in IMCD cells (Fig. 2B) . Taken together, these results confirmed that TNF-α could trigger expression level of miR-21 in IMCD cells in a concentration-and time-dependent manner
To investigate the effect of miR-21 on the expression of CD40 induced by TNF-α in IMCD cells, we overexpressed and silenced the expression of miR-21 in IMCD cells. After transfection with miR-21 mimics for 48 h, a significant increase in the miR-21 expression level was observed in IMCD cells compared with the NC mimics group (Fig. 2C) . Moreover, an inhibitor of miR-21 strikingly reduced the expression level of miR-21 in IMCD cells (Fig. 2D) . Then, the IMCD cells transfected with miR-21 mimics or inhibitor were treated with TNF-α (20 μg/L) for 24 h, and the mRNA and protein expression of CD40 was measured. The results showed that overexpression of miR-21 obviously decreased the expression of CD40 mRNA and protein in IMCD cells, compared with the TNF-α group (Fig. 2E and F) . Knockdown of miR-21 remarkably increased the expression of CD40 mRNA and protein compared with TNF-α group (Fig. 2G and H) , suggesting that miR-21 might regulate the expression of CD40 induced by TNF-α in IMCD cells.
SIRT1 inhibits TNF-α-induced CD40 expression via NF-κB in IMCD cells
The IMCD cells were treated with different concentrations of TNF-α (10, 20 and 40 μg/L) for 24 h, and the expression of SIRT1 and Ac-p65 was determined. The results showed that treatment of IMCD cells with TNF-α significantly decreased the expression of SIRT1 mRNA and protein and increased the expression of Ac-p65 protein in a concentration-dependent manner (Fig. 3A-C) . We further studied the time courses of SIRT1 and Ac-p65 expression in (Fig. 3D-F) .
To identify the role of SIRT1 in the expression of Ac-p65 and CD40 in TNF-α-induced IMCD cells, we overexpressed SIRT1 in IMCD cells. After treatment with the SIRT1 activator SRT1720 (10 μM) or the pcDNA3.1(+)-SIRT1 plasmid, increases in SIRT1 protein were observed in IMCD cells, compared with the control groups ( Fig. 3G and K) . Then, the IMCD cells were pretreated with SRT1720 for 1 h or pcDNA3.1(+)-SIRT1 for 48 h prior to stimulation with TNF-α (20μg/L) for 24 h. The results showed that SRT1720 significantly reduced the mRNA and protein expression of CD40 induced by TNF-α in IMCD cells as well as the expression of Ac-p65 (Fig. 3H-J) . Overexpression of SIRT1 further supported the above results by inducing decreased expression of Ac-p65 and CD40, compared with the TNF-α group (Fig. 3L-N) . To further affirm the above results, we silenced the expression of SIRT1 in IMCD cells. Treatment of IMCD cells with the SIRT1 inhibitors Ex527 (1 μM) and sirtinol (10 μM) or SIRT1 siRNA strikingly reduced the expression of SIRT1 (Fig. 3A, Fig. 4D ). Then the IMCD cells were pretreated with Ex527 or sirtinol for 1 h or SIRT1 siRNA for 48 h prior to stimulation with TNF-α (20 μg/L) for 24 h. The results showed that Ex527 or sirtinol obviously promoted TNF-α-induced CD40 and Ac-p65 expression in IMCD cells (Fig. 4A-C) . Moreover, knockdown of SIRT1 remarkably increased the expression CD40 mRNA and protein and Ac-p65 protein in TNF-α-induced IMCD cells (Fig. 4E-G) .
To examine whether NF-κBp65 was involved in the expression of CD40 in IMCD cells treated with TNF-α, we silenced the expression of NF-κBp65. Treatment of IMCD cells with the NF-κB inhibitor PDTC or NF-κBp65 siRNA strikingly decreased the expression of Ac-p65 ( Fig. 5A and C) . Then the IMCD cells were pretreated with PDTC for 1 h or NF-κBp65 siRNA for 48 h prior to stimulation with TNF-α (20 μg/L) for 24 h. The results showed that PDTC strikingly decreased the expression of CD40 mRNA and protein in IMCD cells compared with the TNF-α group (Fig. 5A and B) . Knockdown of NF-κBp65 further supported the above results by decreasing the expression of CD40 compared with the TNF-α group (Fig. 5D and  E) .
To further confirm whether SIRT1 regulated TNF-α-induced CD40 expression through the NF-κB pathway, the NF-κBp65-knockdown cells were pretreated with pcDNA3.1(+)-SIRT1 for 48 h and then stimulated with TNF-α (20 μg/L) for 24 h. The results revealed that CD40 expression was significantly decreased in the combination (NF-κBp65 siRNA and pcDNA3.1(+)-SIRT1) treatment group compared with the single treatment group in TNF-α-induced IMCD cells (Fig. 5F ). These results imply that SIRT1 can regulate TNF-α-induced CD40 expression in IMCD cells via suppression of NF-κB signalling.
miR-21 diminishes TNF-α-induced CD40 expression through the SIRT1-NF-κB pathway in IMCD cells
To clarify the mechanism underlying miR-21-regulated CD40 expression in IMCD cells, the SIRT1 pathway was introduced. IMCD cells transfected with miR-21 mimics were treated with TNF-α (20 μg/L) for 24 h, and the expression of SIRT1 mRNA and protein and Ac-p65 protein was examined. The results showed that transfection with miR-21 mimics strikingly augmented the expression of SIRT1 mRNA and protein and impeded the expression of Acp65 protein (Fig. 6A-C) . Consistently, an inhibitor of miR-21 significantly decreased the expression of SIRT1 mRNA and protein in IMCD cells stimulated with TNF-α, concomitant with the increase in Ac-p65 protein (Fig. 6D-F) . The results indicated that miR-21 can regulate the SIRT1-NF-κB pathway in IMCD cells stimulated with TNF-α.
To further assess the correlation between the miR-21-regulated SIRT1 signalling pathway and CD40 expression in TNF-α-induced IMCD cells, we inhibited the expression of SIRT1. The SIRT1-knockdown cells were pretreated with miR-21 mimics for 48 h and then stimulated with TNF-α (20 μg/L) for 24 h. The results revealed that transfection with miR-21 mimics significantly decreased the expression of CD40 protein and mRNA and Ac-p65 protein in TNF-α-induced IMCD cells, which was prominently attenuated by pretreatment with SIRT1 siRNA (Fig. 6G-I) . Together, our data suggested that miR-21inhibited CD40 expression induced by TNF-α through SIRT1-NF-κB signalling in IMCD cells.
Discussions
It is widely accepted that dysfunctional miRNA expression, specifically the expression of miR-21, plays a role in the up-regulation of mechanisms responsible for the progression of kidney injury [35, 36] . The renal expression level of miR-21 was significantly elevated during different phases of renal ischaemia-reperfusion injury [36, 37] . The present study indicated that TNF-α induced the expression level of miR-21 in IMCD cells in a concentration-and time-dependent manner. Recently, miRs have drawn more attention due to their prominent function in inflammatory processes in renal disease. Sheedy et al. have reported that transfection with a miR-21 precursor into human peripheral blood mononuclear cells treated with LPS promotes the production of anti-inflammatory factor IL-10 [38] . We found that mimics of miR-21 decreased the expression of CD40 mRNA and protein, whereas an inhibitor of miR-21 increased the expression of CD40 mRNA and protein in IMCD cells exposed to TNF-α, suggesting that miR-21 may regulate CD40 expression in IMCD cells. Nevertheless, it has been reported that suppression of miR-21 causes a reduction in the proinflammatory cytokine TNF-α and monocyte chemoattractant protein-1 in a mouse model of type 2 diabetes [38] . Another study revealed that overexpression of miR-21 resulted in upregulation of TNF-α and interferon-γ in B6 T cells [39] . Therefore, these results indicate that miR-21 may play different roles in various types of cells and tissues in response to a variety of stimuli.
Preclinical and clinical studies have shown that the pro-inflammatory cytokine CD40 plays a crucial role in the onset and maintenance of the inflammatory reaction [14] , and activation of CD40 contributes to renal inflammation and injury in vivo and in vitro [40, 41] . In the present study, TNF-α significantly increased CD40 expression at mRNA and protein levels in IMCD cells in a time-and concentration-dependent manner. In agreement with our results, CD40 expression was up-regulated in renal proximal tubular epithelial cells and human renal mesangial cells in response to transforming growth factor-beta (TGF-β) and soluble monosodium urate, respectively [42, 43] . These results show that the increased expression of CD40 appears to trigger inflammation in renal tissue in response to inducers such as inflammatory stimuli and TGF-β, and then aggravates the inflammatory state within renal tissue. In addition, our previous studies have reported a functional link between SIRT1 activity and CD40 expression in CRL-1730 endothelial cells and 3T3-L1 adipocytes [19, 20] . In these findings, SIRT1 exerts its inhibitory effects on CD40 expression in TNF-α-induced IMCD cells by deacetylating the RelA/p65 subunit of NF-κB at lysine 310, a critical site for NF-κB activation. In accordance with the above results, the present study provided evidence that the expression levels of CD40 and the p65 subunit were downregulated by activating SIRT1 and that these effects were reversed by inhibiting SIRT1 activity, suggesting that the anti-CD40 effect of SIRT1 is attributable, at least in part, to inhibition of the NF-κB pathway.
Studies have highlighted the critical role of miRs in the progression of renal disease through regulation of target gene expression [44, 45] , and SIRT1 was shown to be regulated by miRs [32, 33, 46, 47] . It has been revealed that miR-21 can protect the kidney against ischaemia-reperfusion injury by inhibiting the inflammatory response and apoptosis, which is one of the mechanisms involved in the protective effect of renal ischaemic preconditioning in vivo and in vitro [48, 49] . Our present study demonstrated that miR-21 overexpression strikingly augmented the expression of SIRT1 protein and mRNA, while inhibition of miR-21 significantly decreased the expression of SIRT1 protein and mRNA in IMCD cells treated with TNF-α, implying that miR-21 may regulate the expression of SIRT1 in IMCD cells. In addition, it has been reported that transfection of a miR-21 precursor into human peripheral blood mononuclear cells treated with LPS blocks NF-κB activity [38] . A recent study also revealed that transfection with miR-21 mimics strikingly impeded the intra-nuclear NF-κB p65 levels in LPS-induced macrophages [31] . Our results found that miR-21 overexpression obviously impeded the expression of Ac-p65 protein, whereas inhibition of miR-21 increased TNF-α-induced expression of Ac-p65 in IMCD cells. Our data suggest that miR-21 can inhibit the activation of NF-κB in IMCD cells. Moreover, it has been demonstrated that inhibition of the miR-34a enhances SIRT1 signalling and then decreases acetylation of NF-κBp65 in macrophages [50] . A recent study found that reduced miR-23b-3p expression inhibited acetylation of NF-κB expression by rescuing SIRT1 expression in high glucose-induced diabetic retinopathy [51] . The present study showed that knockdown of SIRT1 abolished the inhibitory effect of miR-21 on the TNF-α-induced the expression of Ac-p65 in IMCD cells, indicating that miR-21 inhibits the activation of NF-κB in TNF-α-induced IMCD cells via SIRT1 signalling. This seems to be consistent with the results of the previous studies. However, there is much to learn about the correlation between the miR-21-regulated SIRT1-NF-κB pathway and CD40 expression in TNF-α-induced IMCD cells. Accordingly, SIRT1 siRNA was applied to further clarify whether SIRT1 was involved in the CD40 inhibitory effects of miR-21. We found that knockdown of SIRT1 diminished the inhibitory effect of miR-21 on TNF-α-induced CD40 expression in IMCD cells, suggesting that SIRT1 is associated with the inhibitory effects of miR-21 on TNF-α-induced CD40 expression. Taken together, these findings support the notion that miR-21 inhibits CD40 expression in IMCD cells through a SIRT1-dependent signalling pathway. However, the mechanism involved in miR-21 regulation of SIRT1-NF-κB is still unclear, and needs to be explored in our next study.
In conclusion, our results indicate that miR-21 can regulate TNF-α-induced inflammatory responses in IMCD cells through the SIRT1-NF-κB pathway. Accordingly, our research provides valuable insight into understanding the anti-inflammatory effect of miR-21 and suggests a promising therapeutic prospect, through miR-21 overexpression, for prevention and treatment of damage from inflammation-related diseases.
